Cargando…
Malignant tumours of the kidney: imaging strategy
Primitive malignant renal tumours comprise 6% of all childhood cancers. Wilms tumour (WT) or nephroblastoma is the most frequent type accounting for more than 90%. Imaging alone cannot differentiate between these tumours with certainty but it plays an important role in screening, diagnostic workup,...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861760/ https://www.ncbi.nlm.nih.gov/pubmed/20432020 http://dx.doi.org/10.1007/s00247-010-1584-z |
_version_ | 1782180671855263744 |
---|---|
author | Smets, Anne M. de Kraker, Jan |
author_facet | Smets, Anne M. de Kraker, Jan |
author_sort | Smets, Anne M. |
collection | PubMed |
description | Primitive malignant renal tumours comprise 6% of all childhood cancers. Wilms tumour (WT) or nephroblastoma is the most frequent type accounting for more than 90%. Imaging alone cannot differentiate between these tumours with certainty but it plays an important role in screening, diagnostic workup, assessment of therapy response, preoperative evaluation and follow-up. The outcome of WT after therapy is excellent with an overall survival around 90%. In tumours such as those where the outcome is extremely good, focus can be shifted to a risk-based stratification to maintain excellent outcome in children with low risk tumours while improving quality of life and decreasing toxicity and costs. This review will discuss the imaging issues for WT from the European perspective and briefly discuss the characteristics of other malignant renal tumours occurring in children and new imaging techniques with potential in this matter. |
format | Text |
id | pubmed-2861760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-28617602010-05-10 Malignant tumours of the kidney: imaging strategy Smets, Anne M. de Kraker, Jan Pediatr Radiol Review Primitive malignant renal tumours comprise 6% of all childhood cancers. Wilms tumour (WT) or nephroblastoma is the most frequent type accounting for more than 90%. Imaging alone cannot differentiate between these tumours with certainty but it plays an important role in screening, diagnostic workup, assessment of therapy response, preoperative evaluation and follow-up. The outcome of WT after therapy is excellent with an overall survival around 90%. In tumours such as those where the outcome is extremely good, focus can be shifted to a risk-based stratification to maintain excellent outcome in children with low risk tumours while improving quality of life and decreasing toxicity and costs. This review will discuss the imaging issues for WT from the European perspective and briefly discuss the characteristics of other malignant renal tumours occurring in children and new imaging techniques with potential in this matter. Springer-Verlag 2010-04-30 2010 /pmc/articles/PMC2861760/ /pubmed/20432020 http://dx.doi.org/10.1007/s00247-010-1584-z Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Review Smets, Anne M. de Kraker, Jan Malignant tumours of the kidney: imaging strategy |
title | Malignant tumours of the kidney: imaging strategy |
title_full | Malignant tumours of the kidney: imaging strategy |
title_fullStr | Malignant tumours of the kidney: imaging strategy |
title_full_unstemmed | Malignant tumours of the kidney: imaging strategy |
title_short | Malignant tumours of the kidney: imaging strategy |
title_sort | malignant tumours of the kidney: imaging strategy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861760/ https://www.ncbi.nlm.nih.gov/pubmed/20432020 http://dx.doi.org/10.1007/s00247-010-1584-z |
work_keys_str_mv | AT smetsannem malignanttumoursofthekidneyimagingstrategy AT dekrakerjan malignanttumoursofthekidneyimagingstrategy |